本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.05
-1.0300-8.53%
成交量:26.34萬
成交額:296.77萬
市值:3.85億
市盈率:-9.98
高:12.37
開:12.11
低:10.96
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:2.85
換手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.18
市盈率(LYR):-11.28

資料載入中...

2022/08/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/08/08

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/08

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K/A [Amend] - Current report
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/21

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals